Yang F Y, Criado E, Schwartz J A, Keagy B A, Wilcox B R
Department of Surgery, University of North Carolina Memorial Hospital, Chapel Hill 27514.
South Med J. 1988 Jun;81(6):701-6. doi: 10.1097/00007611-198806000-00005.
A fistula between the trachea and the innominate artery, a potentially fatal complication of tracheostomy, can be managed successfully. We have derived several guidelines from our experience with one such case and from a review of the 36 cases reported in the literature over the last decade. Diagnosis must be established before exsanguination occurs. Bronchoscopy and angiography are often nondiagnostic. Control of hemorrhage and a patent airway are the initial goals of treatment. Interruption of the innominate artery is the definitive treatment, with a low rebleeding rate (7%, 1/14 cases) and good long-term survival (64%, 9/14 cases). Maintenance of continuity of the innominate artery is contraindicated, because of a high rebleeding rate (60%, 6/10 cases) and poor long-term survival (10%, 1/10 cases). There is no convincing evidence that interruption of the innominate artery causes significant neurologic or vascular compromise.
气管与无名动脉之间的瘘管是气管切开术的一种潜在致命并发症,但可以成功处理。我们从处理这样一例病例的经验以及对过去十年文献报道的36例病例的回顾中得出了几条指导原则。必须在发生大出血之前做出诊断。支气管镜检查和血管造影通常无法确诊。控制出血和保持气道通畅是治疗的首要目标。阻断无名动脉是确定性治疗方法,再出血率低(7%,14例中的1例),长期生存率良好(64%,14例中的9例)。由于再出血率高(60%,10例中的6例)和长期生存率低(10%,10例中的1例),禁忌维持无名动脉的连续性。没有令人信服的证据表明阻断无名动脉会导致严重的神经或血管损害。